New! Sign up for our free email newsletter.
Science News
from research organizations

Removing more tissue during breast cancer surgery reduces by half the need for second procedure

Date:
May 30, 2015
Source:
Yale Cancer Center
Summary:
Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study.
Share:
FULL STORY

Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study. The findings were published online May 30 in the New England Journal of Medicine and presented at the 2015 Annual Meeting of the American Society of Clinical Oncology in Chicago.

Nearly 300,000 women in the United States are diagnosed with breast cancer each year; more than half undergo breast-conserving surgery with a partial mastectomy to remove the disease. However, between 20% and 40% of patients who undergo this procedure have "positive margins," or cancer cells found at the edge of what is removed. The presence of positive margins often leads to a second surgery to ensure that no cancer remains. The Yale study explored how removing more tissue all the way around the tumor site during the initial surgery -- known as cavity shave margins (CSM) -- could reduce the need for a second surgery.

In this study of 235 patients with breast cancer ranging from stage 0 to stage III, surgeons performed a partial mastectomy as they normally would. Patients were then randomized in the operating room to either have additional CSM removed or not.

"Despite their best efforts, surgeons could not predict where the cancer was close to the edge," said the study's lead author, Dr. Anees Chagpar, associate professor of surgery (oncology) at Yale School of Medicine and director of The Breast Center at Smilow Cancer Hospital at Yale-New Haven. "Taking cavity shave margins cut the positive margin rate in half, without compromising cosmetic outcome or increasing complication rates." Patients in the study will be followed for five years to evaluate the impact of the technique on recurrence rates.

"This randomized controlled trial has the potential to have a huge impact for breast cancer patients," Chagpar said. "No one likes going back to the operating room, especially not the patients who face the emotional burden of another surgery."

Patients on the study were enrolled at Smilow Cancer Hospital at Yale-New Haven.

Additional authors on the study include Brigid K. Killelea, M.D.; Meghan Butler; Karen Stavris; Fangyong Li; Xiaopan Yao; Veerle Bossuyt, M.D.; Malini Harigopal, M.D.; Donald R. Lannin, M.D.; Lajos Pusztai, M.D.; Nina R. Horowitz, M.D., all from Yale University; and Theodore N. Tsangaris, M.D., of Thomas Jefferson University Hospital.


Story Source:

Materials provided by Yale Cancer Center. Original written by Vicky Agnew. Note: Content may be edited for style and length.


Journal Reference:

  1. Anees B. Chagpar et al. A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer. New England Journal of Medicine, 2015 DOI: 10.1056/NEJMoa1504473

Cite This Page:

Yale Cancer Center. "Removing more tissue during breast cancer surgery reduces by half the need for second procedure." ScienceDaily. ScienceDaily, 30 May 2015. <www.sciencedaily.com/releases/2015/05/150530102209.htm>.
Yale Cancer Center. (2015, May 30). Removing more tissue during breast cancer surgery reduces by half the need for second procedure. ScienceDaily. Retrieved March 28, 2024 from www.sciencedaily.com/releases/2015/05/150530102209.htm
Yale Cancer Center. "Removing more tissue during breast cancer surgery reduces by half the need for second procedure." ScienceDaily. www.sciencedaily.com/releases/2015/05/150530102209.htm (accessed March 28, 2024).

Explore More

from ScienceDaily

RELATED STORIES